Intracranial hypertension induced by rofecoxib

Saiju Jacob; Yusuf A Rajabally

doi:10.1111/j.1526-4610.2005.05013.x

Intracranial hypertension induced by rofecoxib

Saiju Jacob, Yusuf A Rajabally

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Abstract

Several secondary causes are implicated in the etiology of idiopathic intracranial hypertension. Rofecoxib is a selective cyclo-oxygenase (COX)-2 inhibitor, now being increasingly used in place of nonselective nonsteroidal anti-inflammatory drugs (NSAIDs). We report a case of intracranial hypertension in a 69-year-old man 3 weeks after the commencement of rofecoxib therapy with reversal of clinical findings on drug withdrawal.

Original language	English
Pages (from-to)	75-6
Number of pages	2
Journal	Headache
Volume	45
Issue number	1
DOIs	https://doi.org/10.1111/j.1526-4610.2005.05013.x
Publication status	Published - Jan 2005

Keywords

Aged
Anti-Inflammatory Agents, Non-Steroidal/adverse effects
Arthritis, Rheumatoid/drug therapy
Cyclooxygenase Inhibitors/adverse effects
Humans
Intracranial Hypertension/chemically induced
Lactones/adverse effects
Male
Sulfones/adverse effects

Access to Document

10.1111/j.1526-4610.2005.05013.x

Cite this

@article{dd4764a2294d4a0fa1ab89161a00daca,

title = "Intracranial hypertension induced by rofecoxib",

abstract = "Several secondary causes are implicated in the etiology of idiopathic intracranial hypertension. Rofecoxib is a selective cyclo-oxygenase (COX)-2 inhibitor, now being increasingly used in place of nonselective nonsteroidal anti-inflammatory drugs (NSAIDs). We report a case of intracranial hypertension in a 69-year-old man 3 weeks after the commencement of rofecoxib therapy with reversal of clinical findings on drug withdrawal.",

keywords = "Aged, Anti-Inflammatory Agents, Non-Steroidal/adverse effects, Arthritis, Rheumatoid/drug therapy, Cyclooxygenase Inhibitors/adverse effects, Humans, Intracranial Hypertension/chemically induced, Lactones/adverse effects, Male, Sulfones/adverse effects",

author = "Saiju Jacob and Rajabally, {Yusuf A}",

year = "2005",

month = jan,

doi = "10.1111/j.1526-4610.2005.05013.x",

language = "English",

volume = "45",

pages = "75--6",

journal = "Headache",

issn = "0017-8748",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Intracranial hypertension induced by rofecoxib

AU - Jacob, Saiju

AU - Rajabally, Yusuf A

PY - 2005/1

Y1 - 2005/1

N2 - Several secondary causes are implicated in the etiology of idiopathic intracranial hypertension. Rofecoxib is a selective cyclo-oxygenase (COX)-2 inhibitor, now being increasingly used in place of nonselective nonsteroidal anti-inflammatory drugs (NSAIDs). We report a case of intracranial hypertension in a 69-year-old man 3 weeks after the commencement of rofecoxib therapy with reversal of clinical findings on drug withdrawal.

AB - Several secondary causes are implicated in the etiology of idiopathic intracranial hypertension. Rofecoxib is a selective cyclo-oxygenase (COX)-2 inhibitor, now being increasingly used in place of nonselective nonsteroidal anti-inflammatory drugs (NSAIDs). We report a case of intracranial hypertension in a 69-year-old man 3 weeks after the commencement of rofecoxib therapy with reversal of clinical findings on drug withdrawal.

KW - Aged

KW - Anti-Inflammatory Agents, Non-Steroidal/adverse effects

KW - Arthritis, Rheumatoid/drug therapy

KW - Cyclooxygenase Inhibitors/adverse effects

KW - Humans

KW - Intracranial Hypertension/chemically induced

KW - Lactones/adverse effects

KW - Male

KW - Sulfones/adverse effects

U2 - 10.1111/j.1526-4610.2005.05013.x

DO - 10.1111/j.1526-4610.2005.05013.x

M3 - Article

C2 - 15663617

SN - 0017-8748

VL - 45

SP - 75

EP - 76

JO - Headache

JF - Headache

IS - 1

ER -

Intracranial hypertension induced by rofecoxib

Abstract

Keywords

Access to Document

Fingerprint

Cite this